We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications.
- Authors
Meyer, Emily J.; Gabb, Genevieve; Jesudason, David
- Abstract
The article offers information on association between sodium–glucose cotransporter 2 (SGLT2) inhibitors and diabetic ketoacidosis (DKA) (1–4). Topics discussed include DKA often occurs in the absence of marked hyperglycemia; observation of DKA with offlabel drug use for weight loss or insulin resistance; and information on similarity between SGLT2 inhibitor–associated DKA illness prodrome and DKA in type 1 diabetes (T1D).
- Publication
Diabetes Care, 2018, Vol 41, Issue 4, pe47
- ISSN
0149-5992
- Publication type
Academic Journal
- DOI
10.2337/dc17-1721